Gasser P, Tarchevskaya SS, Guntern P, Brigger D, Ruppli R, Zbren N, et al
PMID 29260458
Research overview Related protocols and comparisons BPC-157 (5 mg Vial) Dosage Protocol BPC-157 (10 mg Vial) Dosage Protocol BPC-157 + TB-500 (20 mg Blend) Dosage Protocol TB-500 (5 mg) + BPC-157 (5 mg) Stack Dosage Protocol Tri-Heal (45 mg Blend) Dosage Protocol GLOW (70 mg Blend) Dosage Protocol KLOW (80 mg Blend) Dosage Protocol TB-500 (5 mg Vial) Dosage Protocol
It stimulates collagen, elastin, and glycosaminoglycan synthesis, which is why it plays a key structural role in KLOW: while BPC-157 and TB-500 handle the acute repair work, GHK-Cu rebuilds the foundation
It is equally about preventing new fat from being created
Recent research has shown that hyperglycemia induced cellular stress, such as ERS (120) and oxidative stress (119), which stimulate the pyroptotic process in renal cells, and various signaling pathways, such as TLRs/NF-B/NLRP3 inflammasome signalling pathway, TXNIP/NLRP3 inflammasome pathway, ATP/P2X purinergic signalling pathway, and MAPKs/NLRP3 inflammasome signalling pathway (119, 121)